Myriam Pujol

Dr. Myriam Pujol

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Archives of Oral Biology
Verified
Journal Article
Closed access
JDJaime Díaz-Zúñiga
Jaime Díaz-Zúñiga
SMSamanta Melgar-Rodríguez
Samanta Melgar-Rodríguez
GMGustavo Monasterio
Gustavo Monasterio
MPMyriam Pujol
Myriam Pujol
LRLeticia Rojas
Leticia Rojas
Rolando VernalRolando Vernal
Rolando Vernal

Verified
Journal Article
Open access
PDF file
MPMyriam Pujol
Myriam Pujol
TPTautvydas Paskevicius
Tautvydas Paskevicius
ARAlison Robinson
Alison Robinson
SDSimran K Dhillon
Simran K Dhillon
PEPaul Eggleton
Paul Eggleton
Marek MichalakMarek Michalak
Marek Michalak
The infiltration of immune cells into the central nervous system mediates the development of autoimmune neuroinflammatory diseases. We previously showed that the loss of either Fabp5 or calnexin causes resistance to the induction of experimental autoimmune encephalomyelitis (EAE) in mice, an animal model of multiple sclerosis (MS). Here we show that brain endothelial cells lacking either Fabp5 or calnexin have an increased abundance of cell surface CD200 and soluble CD200 (sCD200) as well as decreased T-cell adhesion. In a tissue culture model of the blood–brain barrier, antagonizing the interaction of CD200 and sCD200 with T-cell CD200 receptor (CD200R1) via anti-CD200 blocking antibodies or the RNAi-mediated inhibition of CD200 production by endothelial cells increased T-cell adhesion and transmigration across monolayers of endothelial cells. Our findings demonstrate that sCD200 produced by brain endothelial cells regulates immune cell trafficking through the blood–brain barrier and is primarily responsible for preventing activated T-cells from entering the brain.